Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Multiple Myeloma 4Stomach Neoplasms 3Peptic Ulcer 2Gastritis 2Dyspepsia 2Recurrence 1Lymphoma, B-Cell, Marginal Zone 1Helicobacter Infections 1Chemotherapy Effect 1Carcinoma, Ovarian Epithelial 1

Interventions

Oxaliplatin 64pembrolizumab 48Fluorouracil 44Capecitabine 38Nivolumab 33Leucovorin 32Paclitaxel 28Trastuzumab 19Docetaxel 18Cisplatin 18S 1 (combination) 16Bevacizumab 15Ramucirumab 13Irinotecan 13Drug Therapy 13tislelizumab 12Cyclophosphamide 12fludarabine 10Carboplatin 10Radiotherapy 9Magnetic Resonance Spectroscopy 9trastuzumab deruxtecan 8sintilimab 8Specimen Handling 8Biopsy 8atezolizumab 7Surgical Procedures, Operative 7Gemcitabine 7zolbetuximab 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomach Neoplasms × Clarithromycin × 1 year × Clear all
NCT07211880 2025-10-08

Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study

Zero Helicobacter IGAN Network

Phase NA Completed
1,043 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07068607 2025-08-14

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial

Xijing Hospital of Digestive Diseases

Phase 4 Recruiting
400 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT05742568 2025-07-03

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Xijing Hospital of Digestive Diseases

Phase 4 Completed
124 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡